Search results
Hims & Hers Is Now Selling Semaglutide: Here's What You Should Know
Verywell Health via Yahoo Finance· 3 days agoPhoto Illustration by Amelia Manley for Verywell Health; Hims & Hers Fact checked by Nick...
Hims & Hers Stock Spikes. It’s Taking on Big Pharma With Cheap Obesity Shots.
Barrons.com· 4 days agoA relatively small telehealth company that recently went public wants to take a slice of the big...
Hims & Hers will sell knock-off Ozempic for $199 — and it won’t be approved by FDA
NY Post via Yahoo Finance· 1 day agoHims & Hers announced that it will now be selling a compounded version of popular diabetes and...
Irene Becklund Sells 943 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) Stock
ETF DAILY NEWS· 3 days agoHims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) insider Irene Becklund sold 943 shares of the company’s stock in a transaction dated Friday, May ...
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
NBC Washington· 4 days agoDigital pharmacy startup Hims & Hers Health is introducing access to compounded GLP-1 weight loss...
Hims & Hers says it's selling a GLP-1 weight loss drug for 85% less than Wegovy. Here's the price.
CBS News· 4 days agoDirect-to-consumer pharmaceutical startup Hims & Hers Health said it is selling injectable GLP-1...
Hims & Hers is getting into the weight-loss drug game — and Wall Street is loving it
Business Insider· 4 days agoHims & Hers compounded GLP-1 — the same ingredient as Ozempic — will be priced at $200 a month....
Is Hims & Hers Health (HIMS) a Buy as Wall Street Analysts Look Optimistic?
Zacks via Yahoo Finance· 4 days agoThe average brokerage recommendation (ABR) for Hims & Hers Health (HIMS) is equivalent to a Buy. The...
Hims & Hers Selling GLP-1 Weight Loss Drugs Like Wegovy for 85% Less: What to Know
Healthline via AOL· 2 days agoTelehealth company Hims & Hers announced they will begin selling off-brand GLP-1 drugs similar to...
Hims & Hers is selling an Ozempic knockoff without FDA approval. Here's how
Quartz· 3 days agoThe millennial-skewed telehealth platform Hims & Hers this week joined several online pharmacies in...